These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2808786)
41. Control of calculus formation by a dentifrice containing calcium lactate. Schaeken MJ; van der Hoeven JS Caries Res; 1993; 27(4):277-9. PubMed ID: 8402801 [TBL] [Abstract][Full Text] [Related]
42. Association of glycerol and paraffin in the treatment of ichthyosis in children: an international, multicentric, randomized, controlled, double-blind study. Blanchet-Bardon C; Tadini G; Machado Matos M; Delarue A J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):1014-9. PubMed ID: 22118417 [TBL] [Abstract][Full Text] [Related]
43. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis. Diluvio L; Dattola A; Cannizzaro MV; Franceschini C; Bianchi L G Ital Dermatol Venereol; 2019 Feb; 154(1):32-36. PubMed ID: 30207438 [TBL] [Abstract][Full Text] [Related]
44. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris. Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320 [TBL] [Abstract][Full Text] [Related]
45. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis. Kerdel FA; Draelos ZD; Tyring SK; Lin T; Pillai R J Dermatolog Treat; 2019 Jun; 30(4):333-339. PubMed ID: 30207807 [No Abstract] [Full Text] [Related]
46. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream. Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289 [TBL] [Abstract][Full Text] [Related]
47. Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy. Pariser DM; Green LJ; Stein Gold L; Sugarman JL; Lin T; Pillai R J Drugs Dermatol; 2018 Jul; 17(7):723-726. PubMed ID: 30005093 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of topical hydrating and emollient lotion containing 10% urea ISDINĀ® plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial. Castello M; Milani M G Ital Dermatol Venereol; 2011 Oct; 146(5):321-5. PubMed ID: 21956268 [TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials. Gold LS; Lebwohl MG; Sugarman JL; Pariser DM; Lin T; Martin G; Pillai R; Israel R; Ramakrishna T J Am Acad Dermatol; 2018 Aug; 79(2):287-293. PubMed ID: 29614243 [TBL] [Abstract][Full Text] [Related]
50. Double-blind, randomized trial of scheduled use of a novel barrier cream and an oil-containing lotion for protecting the hands of health care workers. McCormick RD; Buchman TL; Maki DG Am J Infect Control; 2000 Aug; 28(4):302-10. PubMed ID: 10926708 [TBL] [Abstract][Full Text] [Related]
51. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. Verfaille CJ; Vanhoutte FP; Blanchet-Bardon C; van Steensel MA; Steijlen PM Br J Dermatol; 2007 May; 156(5):965-73. PubMed ID: 17263800 [TBL] [Abstract][Full Text] [Related]
52. Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies. Sugarman JL; Weiss J; Tanghetti EA; Bagel J; Yamauchi PS; Stein Gold L; Lin T; Martin G; Pillai R; Israel R J Drugs Dermatol; 2018 Aug; 17(8):855-861. PubMed ID: 30124724 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648 [TBL] [Abstract][Full Text] [Related]
54. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial. NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881 [TBL] [Abstract][Full Text] [Related]
55. Ichthyosis in two dogs. Muller GH J Am Vet Med Assoc; 1976 Dec; 169(12):1313-6. PubMed ID: 1002598 [TBL] [Abstract][Full Text] [Related]
56. Effect of a new moisturizing lotion on immediate and cumulative skin hydration: Two randomized, intra-individual, vehicle- and comparator-controlled studies. Nogueira A; Sidou F; Brocard S J Dermatolog Treat; 2011 Aug; 22(4):221-5. PubMed ID: 20687845 [TBL] [Abstract][Full Text] [Related]
57. Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial. Woolery-Lloyd H; Baumann L; Ikeno H J Cosmet Dermatol; 2010 Mar; 9(1):22-7. PubMed ID: 20367669 [TBL] [Abstract][Full Text] [Related]
58. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis. Bissonnette R; Maari C; Provost N; Bolduc C; Nigen S; Rougier A; Seite S J Cosmet Dermatol; 2010 Mar; 9(1):16-21. PubMed ID: 20367668 [TBL] [Abstract][Full Text] [Related]
59. In situ clinical effects of new dentifrices containing 1.5% arginine and fluoride on enamel de- and remineralization and plaque metabolism. Cantore R; Petrou I; Lavender S; Santarpia P; Liu Z; Gittins E; Vandeven M; Cummins D; Sullivan R; Utgikar N J Clin Dent; 2013; 24 Spec no A():A32-44. PubMed ID: 24156138 [TBL] [Abstract][Full Text] [Related]
60. Effect of a mouthrinse containing calcium lactate on the formation and mineralization of dental plaque. van der Hoeven JS; Schaeken MJ; Creugers TJ Caries Res; 1989; 23(3):146-50. PubMed ID: 2736575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]